Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry.

core needle biopsy diagnosis flow cytometry non‐Hodgkin lymphoma

Journal

Cytometry. Part B, Clinical cytometry
ISSN: 1552-4957
Titre abrégé: Cytometry B Clin Cytom
Pays: United States
ID NLM: 101235690

Informations de publication

Date de publication:
14 Jun 2024
Historique:
revised: 04 05 2024
received: 23 01 2024
accepted: 28 05 2024
medline: 14 6 2024
pubmed: 14 6 2024
entrez: 14 6 2024
Statut: aheadofprint

Résumé

Image-guided core needle biopsies (IG-CNB) represent a minimally invasive approach for obtaining tissue in patients with lymphadenopathy and suspected lymphoma. Despite their utility, diagnostic challenges persist, with lower efficacy compared with excisional biopsies. Our study aimed to evaluate the potential utility of incorporation of flow cytometry (FC) alongside immunohistochemistry (IHC) when performing IG-CNB for suspected lymphoproliferative diseases. Analyzing 170 consecutive cases, guided by ultrasound (n = 94) or computer tomography (n = 76), we employed a diagnostic algorithm, already established in our laboratory practice, utilizing three antibody cocktail-equipped tubes tailored for defining lymphomas, particularly those of B-cell origin. FC expedited the diagnostic process, yielding presumptive results in 87.6% of cases within 48 h, with a positive predictive value of 98%. Addition of FC to routine IHC enhanced the diagnostic rate from 91.2% to 95.3%, reducing IG-CNB failure rate by 45%, from 8.8% to 4.7%. This enhancement was particularly notable for deep-seated sites and in the setting of suspected disease recurrences. Consequently, FC emerges as a valuable adjunctive tool, allowing for the improvement of diagnostic performance, with a particular focus on the ability to quantify the expression of surface markers for targeted therapies, and holding the potential to diminish the necessity for repeat excisional biopsies subsequent to IG-CNB procedures.

Identifiants

pubmed: 38873698
doi: 10.1002/cyto.b.22185
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Progetti di Rilevante Interesse Nazionale Prot. 2017
ID : PPS2X4
Organisme : Piano nazionale ripresa resilienza
ID : MAD-2022-12376707

Informations de copyright

© 2024 International Clinical Cytometry Society.

Références

Agid, R., Sklair‐Levy, M., Bloom, A. I., Lieberman, S., Polliack, A., Ben‐Yehuda, D., Sherman, Y., & Libson, E. (2003). CT‐guided biopsy with cutting‐edge needle for the diagnosis of malignant lymphoma: Experience of 267 biopsies. Clinical Radiology, 58(2), 143–147.
Alaggio, R., Amador, C., Anagnostopoulos, I., Attygalle, A. D., Araujo, I. B. O., Berti, E., et al. (2022). The 5th edition of the World Health Organization classification of Haematolymphoid Tumours: Lymphoid neoplasms. Leukemia, 36(7), 1720–1748.
Arroz, M., Came, N., Lin, P., Chen, W., Yuan, C., Lagoo, A., Monreal, M., de Tute, R., Vergilio, J. A., Rawstron, A. C., & Paiva, B. (2016). Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting. Cytometry. Part B, Clinical Cytometry, 90(1), 31–39.
Bellesi, S., Fiorita, A., Corina, L., D'Agostino, G., Maiolo, E., Scarano, E., Iacovelli, C., Alma, E., Bellisario, F., Malafronte, R., D'Alò, F., Larocca, L. M., Hohaus, S., & Galli, J. (2023). The role of flow cytometry for the timely diagnosis of lymphoma in the head and neck district. Oral Oncology Reports, 6, 100045.
Bellisario, F., Attili, F., Campana, F., Borrelli de Andreis, F., Bellesi, S., Maiolo, E., Alma, E., Malafronte, R., Macis, G., Larocca, L. M., Annunziata, S., D'Alò, F., & Hohaus, S. (2023). Endoscopic ultrasound‐guided fine needle biopsy in the diagnostic work‐up of deep‐seated lymphadenopathies and spleen lesions: A monocentric experience. Diagnostics (Basel), 13(17), 2839.
Ben‐Yehuda, D., Polliack, A., Okon, E., Sherman, Y., Fields, S., Lebenshart, P., Lotan, H., & Libson, E. (1996). Image‐guided core‐needle biopsy in malignant lymphoma: Experience with 100 patients that suggests the technique is reliable. Journal of Clinical Oncology, 14(9), 2431–2434.
Bisegna, M. L., Cordone, I., Peragine, N., Milani, M. L., Intoppa, S., de Fabritiis, P., Martelli, M., & De Propris, M. S. (2023). Neoplastic bone marrow invasion: rapid exclusion of hematological disease by flow cytometric routine panels. Blood Cells, Molecules & Diseases, 99, 102721.
Chen, C. N., Huang, T. C., Yu, S. C., Ko, J. Y., & Yang, T. L. (2023). Incorporation of ultrasound‐guided core biopsy with flow cytometry to assist the diagnosis of cervical lymphoma. European Archives of Oto‐Rhino‐Laryngology, 280(3), 1437–1446.
Cherian, S., & Fromm, J. R. (2018). Evaluation of primary mediastinal large B cell lymphoma by flow cytometry. Cytometry. Part B, Clinical Cytometry, 94(3), 459–467.
Chi, P. D., Freed, N. S., Wake, L., Page, C., Smith, L. M., Amador, C., et al. (2018). A simple and effective method for flow cytometric study of lymphoid malignancies using needle core biopsy specimens. Cytometry Part B (Clinical Cytometry), 94B, 793–799.
Cordone, I., Masi, S., Carosi, M., Vidiri, A., Marchesi, F., Marino, M., Telera, S., Pasquale, A., Mengarelli, A., Conti, L., Pescarmona, E., Pace, A., & Carapella, C. M. (2016). Brain stereotactic biopsy flow cytometry for central nervous system lymphoma characterization: Advantages and pitfalls. Journal of Experimental & Clinical Cancer Research, 35(1), 128.
Corrente, F., Bellesi, S., Puggioni, P. L., D'Alo’, F., Cuccaro, A., Maiolo, E., Attili, F., Meacci, E., Scarano, E., Lodoli, C., Pacelli, F., Larocca, L. M., De Stefano, V., & Hohaus, S. The Utility Of The Forward Scatter Parameter In The Flow‐Cytometric Evaluation Of Lymph Node Cell Suspension To Identify B Cell Lymphomas. Abstract release date: 05/17/18, EHA Library—EHA Abstract Book 2018. Corrente F. 06/14/18; 216597; PB2342.
Craig, F. E., & Foon, K. A. (2008). Flow cytometric immunophenotyping for hematologic neoplasms. Blood, 111(8), 3941–3967.
Cuenca‐Jimenez, T., Chia, Z., Desai, A., Moody, A., Ramesar, K., Grace, R., & Howlett, D. C. (2021). The diagnostic performance of ultrasound‐guided core biopsy in the diagnosis of head and neck lymphoma: Results in 226 patients. International Journal of Oral and Maxillofacial Surgery, 50(4), 431–436.
D'Arena, G., Vitale, C., Rossi, G., Coscia, M., Omedè, P., D'Auria, F., Statuto, T., Valvano, L., Ciolli, S., Gilestro, M., Molica, S., Bellesi, S., Topini, G., Panichi, V., Autore, F., Innocenti, I., Musto, P., Deaglio, S., Laurenti, L., & del Vecchio, L. (2018). CD200 included in a 4‐marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia. Hematological Oncology, 36, 543–546.
De Kerviler, E., de Bazelaire, C., Mounier, N., Mathieu, O., Brethon, B., Brière, J., Marolleau, J.‐P., Brice, P., Gisselbrecht, C., & Frija, J. (2007). Image‐guided core‐needle biopsy of peripheral lymph nodes allows the diagnosis of lymphomas. European Radiology, 17(3), 843–849.
de Kerviler, E., Guermazi, A., Zagdanski, A. M., Meignin, V., Gossot, D., Oksenhendler, E., Mariette, X., Brice, P., & Frija, J. (2000). Image‐guided core‐needle biopsy in patients with suspected or recurrent lymphomas. Cancer, 89(3), 647–652.
De Larrinoa, A. F., del Cura, J., Zabala, R., Fuertes, E., Bilbao, F., & Lopez, J. I. (2007). Value of ultrasound‐guided core biopsy in the diagnosis of malignant lymphoma. Journal of Clinical Ultrasound, 35(6), 295–301.
Demharter, J., Muller, P., Wagner, T., Schlimok, G., Haude, K., & Bohndorf, K. (2001). Percutaneous core‐needle biopsy of enlarged lymph nodes in the diagnosis and subclassification of malignant lymphomas. European Radiology, 11(2), 276–283.
Demurtas, A., Accinelli, G., Pacchioni, D., Godio, L., Novero, D., Bussolati, G., Palestro, G., Papotti, M., & Stacchini, A. (2010). Utility of flow cytometry immunophenotyping in fine‐needle aspirate cytologic diagnosis of non‐Hodgkin lymphoma: A series of 252 cases and review of the literature. Applied Immunohistochemistry & Molecular Morphology, 18(4), 311–322.
Demurtas, A., Stacchini, A., Aliberti, S., Chiusa, L., Chiarle, R., & Novero, D. (2013). Tissue flow cytometry immunophenotyping in the diagnosis and classification of non‐Hodgkin's lymphomas: A retrospective evaluation of 1,792 cases. Cytometry. Part B, Clinical Cytometry, 84(2), 82–95.
Groneck, L., Quaas, A., Hallek, M., Zander, T., & Weihrauch, M. R. (2016). Ultrasound‐guided core needle biopsies for workup of lymphadenopathy and lymphoma. European Journal of Haematology, 97(4), 379–386.
He, Y., Ji, X., Xie, Y., He, B., Xu, X., Chen, X., et al. (2015). Clinical application of ultrasound‐guided core needle biopsy with multiple punches in the diagnosis of lymphoma. World Journal of Surgical Oncology, 27(13), 126.
Karube, K., Aoki, R., Nomura, Y., Yamamoto, K., Shimizu, K., Yoshida, S., Komatani, H., Sugita, Y., & Ohshima, K. (2008). Usefulness of flow cytometry for differential diagnosis of precursor and peripheral T‐cell and NKcell lymphomas: Analysis of 490 cases. Pathology International, 58(89–97), 12.
Lachar, W. A., Shahab, I., & Joe, S. A. (2007). Accuracy and cost‐effectiveness of Core needle biopsy in the evaluation of suspected lymphoma. A study of 101 cases. Archives of Pathology & Laboratory Medicine, 131(7), 1033–1039.
Li, S., Eshleman, J. R., & Borowitz, M. J. (2002). Lack of surface immunoglobulin light chain expression by flow cytometric immunophenotyping can help diagnose peripheral B‐cell lymphoma. American Journal of Clinical Pathology, 118, 229–234.
Martig, D. S., & Fromm, J. R. (2022). A comparison and review of the flow cytometric findings in classic Hodgkin lymphoma, nodular lymphocyte predominant Hodgkin lymphoma, T cell/histiocyte rich large B cell lymphoma, and primary mediastinal large B cell lymphoma. Cytometry. Part B, Clinical Cytometry, 102(1), 14–25.
Palumbo, G. A., Parrinello, N., Fargione, G., Cardillo, K., Chiarenza, A., Berretta, S., Conticello, C., Villari, L., & di Raimondo, F. (2009). CD200 expression may help in differential diagnosis between mantle cell lymphoma and B‐cell chronic lymphocytic leukemia. Leukemia Research, 33(9), 1212–1216.
Pappa, V. I., Hussain, H. K., Reznek, R. H., Whelan, J., Norton, A. J., Wilson, A. M., Love, S., Lister, T. A., & Rohatiner, A. Z. (1996). Role of image‐guided core needle biopsy in the management of patients with lymphoma. Journal of Clinical Oncology, 14, 2427–2430.
Pizzi, M., Sbaraglia, M., Dal Santo, L., de Bartolo, D., Santoro, L., Scarmozzino, F., Mussolin, L., Pillon, M., Piazza, F., Trentin, L., & Dei Tos, A. P. (2023). Higher accuracy of surgical over core needle biopsy for the diagnosis of lymphoproliferative disorders. International Journal of Laboratory Hematology, 45(4), 516–521.
Rawstron, A. C., Kreuzer, K. A., Soosapilla, A., Spacek, M., Stehlikova, O., Gambell, P., McIver‐Brown, N., Villamor, N., Psarra, K., Arroz, M., Milani, R., de la Serna, J., Cedena, M. T., Jaksic, O., Nomdedeu, J., Moreno, C., Rigolin, G. M., Cuneo, A., Johansen, P., … Montserrat, E. (2018). Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European research initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) harmonisation project. Cytometry. Part B, Clinical Cytometry, 94(1), 121–128.
Stacchini, A., Demurtas, A., Aliberti, S., Francia di Celle, P., Godio, L., & Novero, D. (2007). The usefulness of flow cytometric CD10 detection in the differential diagnosis of peripheral T‐cell lymphomas. American Journal of Clinical Pathology, 128, 854–864.
Syrykh, C., Chaouat, C., Poullot, E., Amara, N., Fataccioli, V., Parrens, M., Traverse‐Glehen, A., Molina, T. J., Xerri, L., Martin, L., Dubois, R., Lacheretz‐Szablewski, V., Copin, M. C., Moreau, A., Chenard, M. P., Cabarrou, B., Lusque, A., Gaulard, P., Brousset, P., & Laurent, C. (2022). Lymph node excisions provide more precise lymphoma diagnoses than core biopsies: A French Lymphopath network survey. Blood, 140(24), 2573–2583.
Tan, L. H. (2009). A practical approach to the understanding and diagnosisof lymphoma: An assessment of the WHO classification based on immunoarchitecture and immuno‐ontogenic principles. Pathology, 41, 305–326.
Tsagarakis, N. J., Papadhimitriou, S. I., Pavlidis, D., Liapis, K., Gortzolidis, G., Kostopoulos, I. V., Marinakis, T., & Paterakis, G. (2020). Contribution of immunophenotype to the investigation and differential diagnosis of Burkitt lymphoma, double‐hit high‐grade B‐cell lymphoma, and single‐hit MYC‐rearranged diffuse large B‐cell lymphoma. Cytometry. Part B, Clinical Cytometry, 98(5), 412–420.
Vallangeon, B. D., Tyer, C., Williams, B., & Lagoo, A. S. (2016). Improved detection of diffuse large B‐cell lymphoma by flow cytometric immunophenotyping—Effect of tissue disaggregation method. Cytometry. Part B, Clinical Cytometry, 90(5), 455–461.
Vandervelde, C., Kamanib, T., Varghese, A., Ramesar, K., Grace, R., & Howlett, D. C. (2008). A study to evaluate the efficacy of image‐guided core biopsy in the diagnosis and management of lymphoma—Results in 103 biopsies. European Journal of Radiology, 66, 107–111.
Wilczynski, A., Görg, C., Timmesfeld, N., Ramaswamy, A., Neubauer, A., Burchert, A., & Trenker, C. (2020). Value and diagnostic accuracy of ultrasound‐guided full core needle biopsy in the diagnosis of lymphadenopathy: A retrospective evaluation of 793 cases. Journal of Ultrasound in Medicine, 39(3), 559–567.
Zinzani, P. L., Colecchia, A., Festi, D., Magagnoli, M., Larocca, A., Ascani, S., Bendandi, M., Orcioni, G. F., Gherlinzoni, F., Albertini, P., Pileri, S. A., Roda, E., & Tura, S. (1998). Ultrasound‐guided core‐needle biopsy is effective in the initial diagnosis of lymphoma patients. Haematologica, 83, 989–992.

Auteurs

Silvia Bellesi (S)

Ematologia, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Gabriele Schiaffini (G)

Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore Facoltà di Medicina e Chirurgia, Rome, Italy.

Andrea Contegiacomo (A)

Radiologia D'Urgenza e Interventistica, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Elena Maiolo (E)

Ematologia, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Camilla Iacovelli (C)

Ematologia, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Rosalia Malafronte (R)

Ematologia, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore Facoltà di Medicina e Chirurgia, Rome, Italy.

Simone D'Innocenzo (S)

Ematologia, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Eleonora Alma (E)

Ematologia, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Flaminia Bellisario (F)

Ematologia, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore Facoltà di Medicina e Chirurgia, Rome, Italy.

Marcello Viscovo (M)

Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore Facoltà di Medicina e Chirurgia, Rome, Italy.

Fabrizia Campana (F)

Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore Facoltà di Medicina e Chirurgia, Rome, Italy.

Alessandra De Filippis (A)

Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore Facoltà di Medicina e Chirurgia, Rome, Italy.

Francesco D'Alò (F)

Ematologia, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore Facoltà di Medicina e Chirurgia, Rome, Italy.

Luigi Maria Larocca (LM)

Patologia Oncoematologica, Dipartimento di Scienze della salute della donna, del bambino e di sanità pubblica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Valerio De Stefano (V)

Ematologia, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore Facoltà di Medicina e Chirurgia, Rome, Italy.

Roberto Iezzi (R)

Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore Facoltà di Medicina e Chirurgia, Rome, Italy.
Radiologia D'Urgenza e Interventistica, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Stefan Hohaus (S)

Ematologia, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore Facoltà di Medicina e Chirurgia, Rome, Italy.

Classifications MeSH